[Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder]
- PMID: 7511289
[Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder]
Abstract
Mutations of the p53 gene are important mechanisms in malignant transformation and are associated with dysregulation of normal cell growth. In the present study the expression of mutated p53-protein and proliferating cell nuclear antigen (PCNA) was investigated in a series of 31 human transitional cell carcinomas (TCC) by immunohistochemistry (IHC). The number of PCNA-positive cells and the pattern of expression was distinct in normal urothelium being confined to the basal cell layer. In dysplastic urothelium and in Carcinoma in situ (CIS) PCNA-immunoreactive nuclei were irregularly distributed throughout all layers. In tumor cell complexes the pattern of PCNA-immunoreactivity was different in papillary and primary infiltrating TCCs. Densitometric quantification of the intensity of the PCNA-reactivity using image analysis revealed an increase from normal to dysplastic urothelium and from dysplastic urothelium to invasive tumors. 21/31 (68%) of the tumors and tumor-associated CIS showed overexpression of p53 varying in percentage, pattern and reaction intensity. The percentage of PCNA-positive cells was higher in tumors overexpressing p53. Double IHC showed colocalization of both molecules in a significant proportion of tumor cells suggesting a link of p53 overexpression and the abnormal proliferative activity. The present results show that p53 over-expression is found in a significant percentage of TCCs and indicate a close association with a defective growth regulation resulting in increased PCNA-levels and enhanced cellular proliferation.
Similar articles
-
Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.Cancer Res. 1999 Jul 15;59(14):3512-7. Cancer Res. 1999. PMID: 10416618
-
The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.Cancer. 1997 Oct 15;80(8):1472-81. Cancer. 1997. PMID: 9338472
-
Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.J Urol. 2001 May;165(5):1481-7. J Urol. 2001. PMID: 11342901
-
The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.J Urol. 2003 Apr;169(4):1219-28. doi: 10.1097/01.ju.0000056085.58221.80. J Urol. 2003. PMID: 12629332 Review.
-
[Clinical applications of molecular biomarkers in urothelial carcinoma of bladder].Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):714-7. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 22321559 Review. Chinese. No abstract available.
Cited by
-
Molecular pathology of non-invasive urothelial carcinomas (part I).Virchows Arch. 2003 Apr;442(4):309-16. doi: 10.1007/s00428-002-0748-0. Epub 2003 Feb 11. Virchows Arch. 2003. PMID: 12715166 Review.
-
Molecular biology of dissemination in bladder cancer--laboratory findings and clinical significance.World J Urol. 1996;14(3):190-6. doi: 10.1007/BF00186899. World J Urol. 1996. PMID: 8806198 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous